Upgrade to SI Premium - Free Trial

Precigen Inc. (PGEN)

7.10 -0.04 (0.56%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form 4 PRECIGEN, INC. For: Aug 26 Filed by: KINDLER JEFFREY B August 28, 2026 8:39 PM - SEC Filing Form 144 PRECIGEN, INC. Filed by: KINDLER JEFFREY B August 26, 2026 4:43 PM - SEC Filing Form 4 PRECIGEN, INC. For: Aug 21 Filed by: AGEE NANCY H August 25, 2026 5:31 PM - SEC Filing Form 4 PRECIGEN, INC. For: Aug 23 Filed by: Lehr Donald P. August 25, 2026 5:29 PM - SEC Filing Form 4 PRECIGEN, INC. For: Aug 23 Filed by: Thomasian Harry Jr. August 25, 2026 5:29 PM - SEC Filing Form 4 PRECIGEN, INC. For: Aug 21 Filed by: Shah Rutul R August 25, 2026 5:27 PM - SEC Filing Form 4 PRECIGEN, INC. For: Aug 23 Filed by: Tennant Phil August 25, 2026 5:26 PM - SEC Filing Form 4 PRECIGEN, INC. For: Aug 23 Filed by: Sabzevari Helen August 25, 2026 5:25 PM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Shah Rutul R August 25, 2026 2:02 PM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Tennant Phil August 25, 2026 1:53 PM - SEC Filing Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers August 25, 2026 7:00 AM - StreetInsider Form 144 PRECIGEN, INC. Filed by: Shah Rutul R August 21, 2026 4:31 PM - SEC Filing Form 4 PRECIGEN, INC. For: Aug 06 Filed by: Shah Rutul R August 7, 2026 5:04 PM - SEC Filing Form SCHEDULE 13G/A PRECIGEN, INC. Filed by: Merck KGaA August 7, 2026 11:23 AM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Shah Rutul R August 6, 2026 1:17 PM - SEC Filing Precigen Inc. (PGEN) PT Raised to $18 at H.C. Wainwright August 5, 2026 6:37 AM - StreetInsider Precigen Inc. (PGEN) Tops Q2 EPS by 6c August 4, 2026 4:18 PM - StreetInsider Form 10-Q PRECIGEN, INC. For: Jun 30 August 4, 2026 4:09 PM - SEC Filing Form 8-K PRECIGEN, INC. For: Aug 04 August 4, 2026 4:06 PM - SEC Filing Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth August 4, 2026 4:01 PM - PR NewsWire Form 4 PRECIGEN, INC. For: Aug 03 Filed by: Shah Rutul R August 3, 2026 6:13 PM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Shah Rutul R August 3, 2026 3:21 PM - SEC Filing Form 4 PRECIGEN, INC. For: Jul 31 Filed by: Thomasian Harry Jr. July 31, 2026 4:26 PM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Thomasian Harry Jr. July 31, 2026 11:12 AM - SEC Filing Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4 July 21, 2026 8:00 AM - PR NewsWire Form 4 PRECIGEN, INC. For: Jun 29 Filed by: Thomasian Harry Jr. July 1, 2026 6:22 PM - SEC Filing Form 4 PRECIGEN, INC. For: Jun 29 Filed by: Shah Rutul R July 1, 2026 6:21 PM - SEC Filing Form 4 PRECIGEN, INC. For: Jun 29 Filed by: Sabzevari Helen July 1, 2026 6:19 PM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Thomasian Harry Jr. July 1, 2026 12:20 PM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Sabzevari Helen June 29, 2026 4:15 PM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Shah Rutul R June 29, 2026 11:31 AM - SEC Filing Form 144 PRECIGEN, INC. Filed by: Thomasian Harry Jr. June 29, 2026 10:59 AM - SEC Filing Form 8-K PRECIGEN, INC. For: Jun 18 June 24, 2026 4:08 PM - SEC Filing Precigen receives FDA orphan drug exclusivity for PAPZIMEOS through 2032 June 15, 2026 6:41 AM - StreetInsider Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging June 15, 2026 6:41 AM - StreetInsider Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices June 11, 2026 8:00 AM - PR NewsWire Full Article List